Albemarle Corp (ALB) Upgraded to Buy by UBS
UBS upgrades Albemarle Corp (ALB) to Buy from Neutral as of December 4, 2025.
Albemarle Corp. engages in the development, manufacture, and marketing of chemicals for consumer electronics, petroleum refining, utilities, packaging, construction, transportation, pharmaceuticals, crop production, food-safety, and custom chemistry services. The company is headquartered in Charlotte, North Carolina and currently employs 8,300 full-time employees. The Company’s segments include Energy Storage, Specialties, and Ketjen. The Energy Storage segment develops and manufactures a range of basic lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride. Its Specialties business optimizes its portfolio of bromine and highly specialized lithium solutions. Its Specialties business serves a variety of industries, including energy, mobility, connectivity, and health. Specialty products are essential in both internal combustion and electric vehicles, from high-voltage cables and powertrains to airbags and tires. Its Ketjen segment includes clean fuels technologies (CFT), fluidized catalytic cracking (FCC) catalysts and additives, and performance catalyst solutions (PCS). The company serves various markets such as grid storage, automotive, aerospace, conventional energy, and others.
Latest news, analyst ratings, earnings reports, dividends, insider trades, and market analysis for Albemarle Corp.
Last Updated: Dec 11, 2025, 11:31 PM · Source: Finnhub.io
UBS upgrades Albemarle Corp (ALB) to Buy from Neutral as of December 4, 2025.
Albemarle Corp (ALB) exceeded Q3 earnings expectations with an EPS of $-0.19.
Albemarle Corp (ALB) announced a quarterly dividend of $0.41 per share.
B of A Securities has downgraded Albemarle Corp (ALB) to Neutral from Buy.
Rothschild & Co initiates coverage on Albemarle Corp (ALB) with a Buy rating.
Sheorey Neal Ravi of Albemarle Corp sold 12,210 shares at $91.26 each.